Skip to main content
SpringerLink
Log in

Expression of activated molecules on CD5+B lymphocytes in autoimmune hemolytic anemia

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

To investigate the expression of activation molecules on CD5+B lymphocytes in peripheral blood of autoimmune hemolytic anemia (AIHA)/Evans patients. The expression of CD80, CD86, and CD69 on CD5+B lymphocytes was detected using flow cytometry in 30 AIHA/Evans patients, 18 normal controls (NC) and nine chronic lymphocytic leukemia (CLL) patients. CD80 on CD5+B lymphocytes in untreated patients was higher than that in remission patients (P < 0.05), NC (P < 0.01) and CLL patients (P < 0.01). CD80 on CD5+B lymphocytes was higher than that on CD5−B lymphocytes in untreated patients (P > 0.05), but lower than those of CD5−B lymphocytes in remission patients and NC (P < 0.05). CD86 on CD5+B lymphocytes of untreated patients was higher than that of remission patients (P < 0.05), NC (P < 0.01). CD86 on CD5+B lymphocytes of CLL was higher than that of NC, remission (P < 0.05), and untreated patients (P > 0.05). CD80 and CD86 on CD5+B lymphocytes was negatively correlated with hemoglobin (HB), C3, C4 (P < 0.05) and positively correlated with reticulocyte (Ret) (P < 0.05). CD69 on CD5+ and CD5−B lymphocytes of CLL was higher than those of AIHA/Evans patients and NC (P < 0.05). The active molecules on CD5+B lymphocytes in peripheral blood of AIHA/Evans patients differ from those on CD5− and clonal CD5+B lymphocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Cioca DP, Kitano K. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia. Leukemia. 2002;16:335–43.

    Article  CAS  PubMed  Google Scholar 

  2. Tibaldi E, Brunati AM, Zonta F, Frezzato F, Gattazzo C, Zambello R, et al. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia. 2011;25:1768–81.

    Article  CAS  PubMed  Google Scholar 

  3. Duan B, Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev. 2006;5:403–8.

    Article  CAS  PubMed  Google Scholar 

  4. Limin Xing, Shao Zonghong Fu, Rong Liu Hong, Jun Shi, Jie Bai, et al. CD5+ B lymphocytes in the bone morrow of autoimmunic hemocytopenia patients and its clinical significance. Chin J Pract Intern Med. 2005;25:39–41 (in Chinese).

    Google Scholar 

  5. Zhang ZN. Standard of diagnosis and curative effect of hematopathy. Beijing: Science Press; 2007. p. 68–71 (in Chinese).

    Google Scholar 

  6. Neff AT. Autoimmune hemolytic anemias. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, editors. Wintrobe’s clinical hematology. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1157–82.

    Google Scholar 

  7. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005;130:325–32.

    Article  PubMed  Google Scholar 

  8. Soldevila G, Raman C, Lozano F. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease. Curr Opin Immunol. 2011;23:310–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Miyazawa M, Boyse EA, Aoki T, Old LJ. Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci. 1968;170:175–93.

    Article  PubMed  Google Scholar 

  10. HayakawaK Hardy RR, Parks DR, Herzenberg LA. The “Ly-1 B” cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med. 1983;157:202–18.

    Article  Google Scholar 

  11. Defrance T, Vanbervliet B, Durand I, Banchereau J. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells. Eur J Immunol. 1989;19:293–9.

    Article  CAS  PubMed  Google Scholar 

  12. Freedman AS, Freeman G, Whitman J, Segil J, Daley J, Levine H, et al. Expression and regulation of CD5 on in vitro activated human B cells. Eur J Immunol. 1989;19:849–55.

    Article  CAS  PubMed  Google Scholar 

  13. Cantaert T, Doorenspleet ME, Francosalinas G, Paramarta JE, Klarenbeek PL, Tiersma Y, et al. Increased numbers of CD5+B lymphocytes with a regulatory phenotype in spondylarthritis. Arthritis Rheum. 2012;64:1859–68.

    Article  CAS  PubMed  Google Scholar 

  14. Caligaris-Cappio F. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood. 1996;87:2615–20.

    CAS  PubMed  Google Scholar 

  15. Bhatia S, Edidin M, Almo SC, Nathenson SG. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol Lett. 2006;104:70–5.

    Article  CAS  PubMed  Google Scholar 

  16. Peggs KS, Allison JP. Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. Br J Haematol. 2005;130:809–24.

    Article  CAS  PubMed  Google Scholar 

  17. Evans DE, Munks MW, Purkerson JM, Parker DC. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40. J Immunol. 2000;164:688–97.

    Article  CAS  PubMed  Google Scholar 

  18. Clatza A, Bonifaz LC, Vignali DA, Moreno J. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation. J Immunol. 2003;171:6478–87.

    Article  CAS  PubMed  Google Scholar 

  19. Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem. 2002;277:7766–75.

    Article  CAS  PubMed  Google Scholar 

  20. Podojil JR, Miller SD. Targeting the B7 family of co-stimulatory molecules: successes and challenges. BioDrugs. 2013;27:1–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Lim TS, Goh JK, Mortellaro A, Lim CT, Hämmerling GJ, Ricciardi-Castagnoli P. CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells. PLoS One. 2012;7:e45185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Vazquez BN, Laguna T, Carabana J, Krangel MS, Lauzurica P. CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal elements. J Immunol. 2009;183:6513–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Vance BA, Harley PH, Backlund PS, Ward Y, Phelps TL, Gress RE. Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface. Arch Biochem Biophys. 2005;438:11–20.

    Article  CAS  PubMed  Google Scholar 

  24. Lewkowich IP, Rempel JD, HayGlass KT. Prevention of allergen-specific, Th2-biased immune responses in vivo: role of increased IL-12 and IL-18 responsiveness. J Immunol. 2005;175:4956–62.

    Article  CAS  PubMed  Google Scholar 

  25. Pajusto M, Ihalainen N, Pelkonen J, Tarkkanen J, Mattila PS. Human in vivo-activated CD45R0(+) CD4(+) T cells are susceptible to spontaneous apoptosis that can be inhibited by the chemokine CXCL12 and IL-2,-6,-7, and-15. Eur J Immunol. 2004;34:2771–80.

    Article  CAS  PubMed  Google Scholar 

  26. Del PG, Del PM, Zucchetto A, Luciano F, BuccisanoF Rossi FM, et al. CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study. Haematologica. 2012;97:279–87.

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from application foundation and advanced technology research project of Tianjin (15JCYBJC27300), National Natural Science Foundation of China (81370607), Science and Technology Foundation of Tianjin Health Bureau (09KZ108).

Author information

Author notes

    Authors and Affiliations

    1. Department of Hematology, General Hospital, Tianjin Medical University, 154 Anshandao, Heping District, Tianjin, 300052, China

      Hongli Zhu, Wenyan Xu, Hong Liu, Huaquan Wang, Rong Fu, Yuhong Wu, Wen Qu, Guojin Wang, Jing Guan, Jia Song, Limin Xing & Zonghong Shao

    Authors
    1. Hongli Zhu
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Wenyan Xu
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Hong Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Huaquan Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Rong Fu
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Yuhong Wu
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Wen Qu
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Guojin Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Jing Guan
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Jia Song
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Limin Xing
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Zonghong Shao
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Limin Xing or Zonghong Shao.

    Ethics declarations

    Conflict of interest

    The authors declare that they have no conflict of interest.

    Additional information

    Z. Shao and L. Xing contributed equally to this manuscript.

    Electronic supplementary material

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Zhu, H., Xu, W., Liu, H. et al. Expression of activated molecules on CD5+B lymphocytes in autoimmune hemolytic anemia. Int J Hematol 103, 545–553 (2016). https://doi.org/10.1007/s12185-016-1964-8

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12185-016-1964-8

    Keywords

    Search

    Navigation